• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成混合纤维基质在坏疽性脓皮病治疗中的应用:病例研究。

Utility of a synthetic hybrid-scale fiber matrix in the management of pyoderma gangrenosum: a case study.

机构信息

Podiatric Medicine and Surgery, Department of Orthopedics, University of Louisville, Louisville, KY.

出版信息

Wounds. 2024 Sep;36(9):323-326. doi: 10.25270/wnds/24058.

DOI:10.25270/wnds/24058
PMID:39378351
Abstract

BACKGROUND

Pyoderma gangrenosum (PG) is a rare skin condition that is challenging for both patients and physicians alike. It is extremely painful and can become debilitating for many patients. PG has a mortality rate of 16% at 8 years, and patients with PG have a threefold risk of death compared to the general population. Currently, the management of PG is not standardized and is somewhat experimental as these wounds are prone to pathergy.

CASE REPORT

A single patient diagnosed with PG of both lower extremities was successfully treated with a protocol that included serial wound debridement with a sterile scrub brush and hydrodebridement followed by application of a synthetic hybrid-scale fiber matrix (SHSFM) dressing. The patient's wounds successfully healed and the resolution was maintained at 2 years, at which time the patient was discharged from the clinic.

CONCLUSION

To the authors' knowledge, this is the first study reporting the use of SHSFM as a primary treatment option for PG.

摘要

背景

坏疽性脓皮病(PG)是一种罕见的皮肤疾病,对患者和医生来说都是极具挑战性的。它非常疼痛,会使许多患者丧失行动能力。PG 在 8 年内的死亡率为 16%,与普通人群相比,患有 PG 的患者死亡风险增加了两倍。目前,PG 的治疗尚未标准化,有些属于试验性治疗,因为这些伤口容易出现假性化脓。

病例报告

一位下肢均患有 PG 的单一患者,成功接受了一项方案的治疗,该方案包括使用无菌擦洗刷进行多次伤口清创和水疗清创,然后使用合成混合鳞片纤维基质(SHSFM)敷料。患者的伤口成功愈合,2 年后仍保持愈合状态,此时患者已从诊所出院。

结论

据作者所知,这是首例报道使用 SHSFM 作为 PG 的主要治疗选择的研究。

相似文献

1
Utility of a synthetic hybrid-scale fiber matrix in the management of pyoderma gangrenosum: a case study.合成混合纤维基质在坏疽性脓皮病治疗中的应用:病例研究。
Wounds. 2024 Sep;36(9):323-326. doi: 10.25270/wnds/24058.
2
Peristomal pyoderma gangrenosum (PG): A simple hydrocolloid dressing technique to promote wound healing.造口周围坏疽性脓皮病(PG):一种促进伤口愈合的简单水胶体敷料技术。
J Am Acad Dermatol. 2015 Sep;73(3):e107-8. doi: 10.1016/j.jaad.2015.05.010.
3
Wound Debridement in Pyoderma Gangrenosum.坏疽性脓皮病的清创术。
Adv Skin Wound Care. 2024 Feb 1;37(2):107-111. doi: 10.1097/ASW.0000000000000092.
4
Negative Pressure Wound Therapy With Instillation and Dwell Time Used to Treat Pyoderma Gangrenosum: A Case Report.灌洗和驻留时间的负压伤口疗法治疗坏疽性脓皮病:一例报告。
Wounds. 2020 Dec;32(12):E59-E61.
5
[Analysis of clinical features and treatment of pyoderma gangrenosum].坏疽性脓皮病的临床特征及治疗分析
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Jun 20;38(6):506-511. doi: 10.3760/cma.j.cn501225-20220317-00068.
6
A Wound Care Specialist's Approach to Pyoderma Gangrenosum.一位伤口护理专家对坏疽性脓皮病的处理方法。
Adv Wound Care (New Rochelle). 2020 Dec;9(12):686-694. doi: 10.1089/wound.2020.1168. Epub 2020 Jun 16.
7
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
8
Pyoderma gangrenosum: a difficult diagnosis best managed in a burn treatment center.坏疽性脓皮病:一种难以诊断的疾病,最好在烧伤治疗中心进行处理。
J Burn Care Res. 2015 May-Jun;36(3):e190-3. doi: 10.1097/BCR.0000000000000119.
9
The role of negative pressure wound therapy (NPWT) on the treatment of pyoderma gangrenosum: A systematic review and personal experience.负压伤口治疗(NPWT)在坏疽性脓皮病治疗中的作用:一项系统评价及个人经验
Wound Repair Regen. 2021 May;29(3):486-494. doi: 10.1111/wrr.12910. Epub 2021 Mar 27.
10
Case Study on Management of Postsurgical Pyoderma Gangrenosum After Spinal Surgery.脊柱手术后坏疽性脓皮病的术后管理病例研究。
J Wound Ostomy Continence Nurs. 2019 Nov/Dec;46(6):543-546. doi: 10.1097/WON.0000000000000587.